TB-500 Research Peptide — Purity, COA & Batch Data
TB-500 is the N-terminally acetylated fragment 17–23 of thymosin β4: seven residues, no methionine, and a mass roughly five times smaller than the parent protein. That difference is the whole identity question, and this file shows how to settle it from a certificate.
The TB-500 peptide is one of the few research peptides where the most common quality problem is not purity but identity: a lot can be clean, correctly labelled TB-500, and still be the wrong molecule if what was supplied is full-length thymosin β4 rather than the fragment.
Compound identity
| Sequence (one-letter) | Ac-LKKTETQ |
| Sequence (three-letter) | Ac-Leu-Lys-Lys-Thr-Glu-Thr-Gln-OH |
| Chain length | 7 amino acids, N-terminally acetylated |
| Position in parent | Residues 17–23 of thymosin β4 |
| Molecular formula | C38H68N10O14 |
| Molecular weight | 889.0 g/mol (acetate form); ≈ 847 as free peptide |
| CAS registry | 885340-08-9 (fragment); 77591-33-4 is full-length thymosin β4 |
| Supplied form | Lyophilised white powder, acetate salt |
Two CAS numbers, two molecules. 885340-08-9 belongs to the acetylated fragment; 77591-33-4 belongs to the 43-residue parent. A certificate quoting the parent CAS with a fragment mass, or the reverse, is internally inconsistent and the lot should be held.
Fragment or parent: which one is on the certificate
Buyers sometimes treat TB-500 and thymosin β4 as the same material sold under two names. They are not. The parent is a 43-residue protein of roughly 4,963 Da with a methionine at position 6; the fragment is the seven-residue acetylated tail of it. The fragment is cheaper to make, more soluble, and carries no methionine to oxidise — which is why most commercial research material is the fragment. If a study reports concentrations for the parent, a fragment lot cannot be substituted on a mass basis without recalculating, because the molar amounts differ by a factor of about five and a half.
How TB-500 identity is confirmed lot by lot
The TB-500 sequence is seven residues long and acetylated at the N-terminus, so the fragment and the parent are separated by mass by an order of magnitude: about 889 for the fragment against roughly 4,963 for full-length thymosin β4. There is no analytical method in routine use that confuses the two on a mass spectrometer, which makes this the easiest identity call in the catalogue — provided the certificate actually states an observed mass.
The second marker is the N-terminal acetyl group. Acetylation adds 42 Da and blocks the N-terminus, so a lot that was never acetylated shows the unmodified mass and will not match the sequence string. On the chromatogram the acetylated fragment is the more hydrophobic of the two by a small margin, which is enough to separate them on a C18 gradient.
- Observed mass near 889, with the adduct stated on the certificate.
- N-terminal acetylation consistent with the stated mass; unacetylated material shows a 42 Da deficit.
- HPLC purity by peak area with the trace attached.
- CAS on the certificate matching the fragment, not the parent protein.
Purity, impurities and what the COA should show
TB-500 purity is easier to hold than the parent protein: because the fragment contains no methionine, the oxidation route that dominates full-length thymosin β4 storage does not apply here. What does appear is incomplete acetylation, chain truncation at either end, and residual counter-ion from the purification step.
Acetylation completeness
Incomplete acetylation leaves a fraction of the lot at −42 Da, which co-elutes closely with the target on many gradients and inflates the purity figure if the method does not resolve it. A method summary that shows the gradient and run time allows a buyer to judge whether the separation was there.
Counter-ions and fill
Acetate content changes the weighed mass without changing the peptide content. Where a lot is sold by fill weight, the certificate should state the form and the fill, and a receiving lab should treat the weighed mass as form-dependent rather than as peptide content.
- Purity by HPLC with the trace attached.
- Observed mass consistent with the acetylated fragment.
- Form stated: acetate, with the counter-ion acknowledged.
- Fill weight and appearance on the same lot number.
- Storage instruction matching the supplied form.
Reconstitution and storage for laboratory stock
TB-500 dissolves cleanly in water and in buffered saline. The fragment is short and hydrophilic, so stocks at 1–5 mg/mL go into solution quickly; what limits the working life of the stock is microbial growth and repeated thawing, not the peptide itself.
| Solvent | Sterile water or phosphate-buffered saline |
| Working stock | 1–5 mg/mL |
| pH | Neutral to slightly acidic; avoid strong alkali, which attacks the threonine hydroxyls over time |
| Aliquoting | Single-use aliquots at −20 °C; avoid refreezing |
| Light | Not the primary sensitivity here, but amber vials cost nothing |
| Powder storage | −20 °C, desiccated, sealed |
Fragment, not parent. If a stock is being compared with published work that used full-length thymosin β4, the two are not interchangeable on a molar basis. Check which molecule the method used before comparing concentrations.
Ordering TB-500: pack sizes and batch documents
The TB-500 peptide is held as ten-vial kits in two fills, with the TB-500 COA issued per lot. Larger quantities and export paperwork are quoted per line.
| Pack | Format | Price |
|---|---|---|
| 5 mg × 10 vials | 10-vial kit | $70 |
| 10 mg × 10 vials | 10-vial kit | $120 |
A TB-500 supplier who quotes the parent protein CAS against a fragment lot has not read the certificate. Prices are per kit as listed at the time of writing and are confirmed on the product page. For mixed lines, larger fills or cross-border documentation see bulk research peptides.
Related reading on TB-500
Need the fragment certificate for a lot?
Send the pack size you are evaluating and we return the sequence, the theoretical mass, the acetylation note and the certificate for that lot.
